Forvse bya Regios Vaca Prato or Hospi or aboraary ony a — Recombinant Human Epidermal Growth Factor Gel REGEN-D 150 For Quick Wouns Healing DESCRIPTION: REGENO''S0 is Human Epderal gow factor based gel produced by recombinant ONA tectciagy and developed by Bharat Bote lnleatonal nite, yderabe, dia ‘RECOMBINANT DNA TECHNOLOGY: “he primary sci ofecembnan eran EGF i a single han palypepie whet saS3eminoaciectan PHARMACEUTICAL FORM: REGEN-D'50isproserotintho form of gol packagadin sos of 75,15, 39, and ‘Sagmbsesincenceratono! 50)9/ compost seh gam of gl cortaos Reconbnaal Huan Eperal Grow Fal 1504 Netty Paren(sod sal... mg (0.1% ww) Propy Parton oes)... 0.2mg (0.02% wy) INoICATIONS: REGEN-D"1Slenseatdtertpilnsabagefetropahicand dane ctu CCONTRAINDICATIOKS: REGEN.D" 150s goreraly wo rated. Honor, he product shold not bo ‘aminstared or rgesod lo person trou tobe hypersensiv to any of te components f th pofuc. Alp, shed nat be acinistared io inal recaling irunceupprosahe ot immune-sunuant therapy or mirune camoromies nis, PREGNANT AND LACTATING MOTHERS: REGEN-D'50 i conranscaledm cases of rognnt and latarg worn, Dosace ‘fer clearing leree, spy hag! so sta covertafulucr area. Thedage ofthe gel doperds on ho speci S20 fh ulcer area fh parivar stents anisodby haphyscian REGEN.0" 150 ADMINISTRATION Proved in go tase REGEN-O'5D so be sroad event pal applcaon am atleted prt using select ava tice aly the usr sex nea, REGEN-O'80 meray stu be cothued upto 8 porod of 15 20 weak Thecorsnuabontthetherapy sete discretanctne ysica, PRECAUTIONS: iis weggets atthe mada ractonas aca he hypereestlysatst ihosubeet REGEN-O"'50 can be scinistred at the same time with oer general encomian rugs bumusinetbaured witcher gowrhlacorcataning rs ‘ADVERSE REACTIONS: REGEN-D'80 nas proven oc gon nti welled. Rash pan. and shininlatonatteappeatonsmaytesoaninsome cases, INSTRUCTIONS FOR USE: 4) Aang shoud be ved fr ndviul pater 2 Tha requrd procauions shut bo lkan to aod doc contact wih he oat io 2) The patent snoudasure hatte le ares ise vey ean befrethe dg oped. Tre pate can civaywathngth ce reagan migsapor ‘alo sou and keoping the uer rb covered wih lan, ry erosings 4) Nol be eset hale product hasnt crosses nee ‘Any umarnted uso ofthe pedi is rttba espns ofthe manvacrer PHARMACEUTICAL PARTICULARS: Category Grow ato, Sorage = Str te col andy lace Sha feet of ex pine on theca. Lares dat: October 2018 et 8 ety @ Bharat Biotech Lesa orn. rates Front page